首页 > 最新文献

Frontiers in medical technology最新文献

英文 中文
Clinical validation of non-contact vital signs in an emergency department setting. 急诊环境中非接触性生命体征的临床验证
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-20 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1728913
Amit S Padaki, Alexa L Zarzour, Kelly R Keene, Carlo A Canepa, Dana R Levin, Erik L Antonsen

Objectives: To evaluate the accuracy of heart rate and respiratory rate acquired by commercially-available device cameras and software.

Methods: One-hundred and eleven subjects were enrolled at an urban academic teaching hospital in Texas. Heart rate (HR) and respiratory rate (RR) measurements were obtained using three commercially-available cameras and processed using software from Presage Technologies. These values were compared to manual counts of a three-lead ECG and end-tidal CO2 from a patient monitor.

Results: The cameras were able to capture HR in 83% of the measurements and RR in 94% of the RR measurements. Camera-acquired HR showed an extremely high correlation with R∼0.99 and a root-mean-square error (RMSE) of 1.62. Respiratory rate showed a high correlation with R∼0.91 and an RMSE of 1.71.

Conclusions: Heart rate and respiratory rate can be accurately acquired using commercially-available camera devices and software for signal processing.

{"title":"Clinical validation of non-contact vital signs in an emergency department setting.","authors":"Amit S Padaki, Alexa L Zarzour, Kelly R Keene, Carlo A Canepa, Dana R Levin, Erik L Antonsen","doi":"10.3389/fmedt.2025.1728913","DOIUrl":"10.3389/fmedt.2025.1728913","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the accuracy of heart rate and respiratory rate acquired by commercially-available device cameras and software.</p><p><strong>Methods: </strong>One-hundred and eleven subjects were enrolled at an urban academic teaching hospital in Texas. Heart rate (HR) and respiratory rate (RR) measurements were obtained using three commercially-available cameras and processed using software from Presage Technologies. These values were compared to manual counts of a three-lead ECG and end-tidal CO2 from a patient monitor.</p><p><strong>Results: </strong>The cameras were able to capture HR in 83% of the measurements and RR in 94% of the RR measurements. Camera-acquired HR showed an extremely high correlation with R∼0.99 and a root-mean-square error (RMSE) of 1.62. Respiratory rate showed a high correlation with R∼0.91 and an RMSE of 1.71.</p><p><strong>Conclusions: </strong>Heart rate and respiratory rate can be accurately acquired using commercially-available camera devices and software for signal processing.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1728913"},"PeriodicalIF":3.8,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12864396/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146121305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: A hybrid, iterative approach, to support the development of fit-for-purpose sensor-derived measures. 更正:一种混合的迭代方法,以支持适合用途的传感器衍生测量的开发。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-16 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1756558
Belen R Ballester, Matthew Reaney, Christina Mack, Salma Ajraoui

[This corrects the article DOI: 10.3389/fmedt.2025.1567537.].

[这更正了文章DOI: 10.3389/fmedt.2025.1567537.]。
{"title":"Correction: A hybrid, iterative approach, to support the development of fit-for-purpose sensor-derived measures.","authors":"Belen R Ballester, Matthew Reaney, Christina Mack, Salma Ajraoui","doi":"10.3389/fmedt.2025.1756558","DOIUrl":"https://doi.org/10.3389/fmedt.2025.1756558","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.3389/fmedt.2025.1567537.].</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1756558"},"PeriodicalIF":3.8,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12857637/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146109245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ventricular suction detection algorithm designed for ventricular assist devices. 为心室辅助装置设计的心室吸力检测算法。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-13 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1748577
Yijiao Wu, Yuzhuo Yang, Xudong Pan, Shunzhou Yu

Background: Ventricular assist devices (VADs) are an effective treatment for end-stage heart failure and can significantly improve patients' quality of life. However, when the rotational speed of the VAD does not match the intraventricular blood volume, ventricular suction may occur. Severe suction can lead to ventricular collapse, making accurate and real-time suction detection critically important.

Methods: Two statistical features and two frequency-domain features were extracted from the pump flow signal to build a classification and regression tree (CART) model. Additionally, a secondary decision-making process was applied using a time-domain threshold.

Results: The proposed method was validated using both in vivo and in vitro experimental data. Experimental results show that, compared to existing suction detection techniques, the proposed approach not only reduces computational complexity but also achieves higher detection accuracy and enhanced algorithmic stability.

Conclusions: The proposed method provides a more efficient and reliable solution for real-time ventricular suction detection, which is crucial for the safe operation of VADs in clinical settings.

背景:心室辅助装置(VADs)是终末期心力衰竭的有效治疗手段,可显著提高患者的生活质量。然而,当VAD的转速与室内血容量不匹配时,可能发生心室吸血。严重的抽吸可导致心室塌陷,因此准确和实时的抽吸检测至关重要。方法:从泵流量信号中提取2个统计特征和2个频域特征,建立分类回归树(CART)模型。此外,采用时域阈值法进行二次决策。结果:该方法得到了体内和体外实验数据的验证。实验结果表明,与现有的吸力检测技术相比,该方法不仅降低了计算复杂度,而且提高了检测精度和算法稳定性。结论:该方法提供了一种更高效、可靠的实时心室吸力检测方案,对VADs临床安全操作至关重要。
{"title":"Ventricular suction detection algorithm designed for ventricular assist devices.","authors":"Yijiao Wu, Yuzhuo Yang, Xudong Pan, Shunzhou Yu","doi":"10.3389/fmedt.2025.1748577","DOIUrl":"https://doi.org/10.3389/fmedt.2025.1748577","url":null,"abstract":"<p><strong>Background: </strong>Ventricular assist devices (VADs) are an effective treatment for end-stage heart failure and can significantly improve patients' quality of life. However, when the rotational speed of the VAD does not match the intraventricular blood volume, ventricular suction may occur. Severe suction can lead to ventricular collapse, making accurate and real-time suction detection critically important.</p><p><strong>Methods: </strong>Two statistical features and two frequency-domain features were extracted from the pump flow signal to build a classification and regression tree (CART) model. Additionally, a secondary decision-making process was applied using a time-domain threshold.</p><p><strong>Results: </strong>The proposed method was validated using both <i>in vivo</i> and <i>in vitro</i> experimental data. Experimental results show that, compared to existing suction detection techniques, the proposed approach not only reduces computational complexity but also achieves higher detection accuracy and enhanced algorithmic stability.</p><p><strong>Conclusions: </strong>The proposed method provides a more efficient and reliable solution for real-time ventricular suction detection, which is crucial for the safe operation of VADs in clinical settings.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1748577"},"PeriodicalIF":3.8,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12835374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146095383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Path dependency and the rescuing of the biomedical research enterprise. 路径依赖与生物医学研究企业的拯救。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-12 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1683835
Zaher Nahle

In 2025, three U.S. agencies within the Department of Health and Human Services (FDA, NIH, CDC) alongside EPA and the Departments of the Navy and Veterans Affairs, began substituting animal testing applications with reliable, human-relevant methods. The impact of this shift in public policy taking place at agencies historically bullish on animal testing is still reverberating in the United States and around the world. Here, we examine the circumstances that enabled such momentous reforms, including the role of the FDA Modernization Act 2.0 in advancing new alternative methods, collectively referred to as NAMs. We explain how animal testing, despite its poor value in predicting the safety and efficacy of drugs in humans, came to dominate drug discovery, basic sciences, and environmental toxicity assessments since the inception of the Federal Food, Drug, and Cosmetic Act (Federal FD&C Act) in 1938. Specifically, we identify critical junctures, including catastrophic government decisions, that made the overall research enterprise acutely dependent on animals, leading to the existing predicament-an indefensible 92% failure rate in translating drugs from preclinical studies to actual therapies. Notably, our analysis chronicles events through the lens of "path dependency," a social sciences phenomenon that occurs when faulty past decisions lock-in future action. Finally, we recognize that our narrative is a departure from the medical establishment account or the talking points of powerful interest groups, including some in the academic elite who continue to shore up animal-centric paradigms in drug development for reasons we also outline.

2025年,美国卫生与公众服务部的三个机构(FDA、NIH、CDC)以及EPA、海军和退伍军人事务部开始用可靠的、与人类相关的方法取代动物试验应用。这一公共政策转变的影响,发生在历来看好动物试验的机构,至今仍在美国和世界各地引起反响。在这里,我们研究了促成这些重大改革的环境,包括FDA现代化法案2.0在推进新的替代方法方面的作用,统称为NAMs。尽管动物实验在预测药物对人类的安全性和有效性方面价值不高,但我们解释了自1938年《联邦食品、药品和化妆品法案》(Federal Food, drug, and Cosmetic Act,简称FD&C Act)颁布以来,动物实验是如何主导药物发现、基础科学和环境毒性评估的。具体来说,我们确定了关键时刻,包括灾难性的政府决策,这使得整个研究企业严重依赖于动物,导致了现有的困境——在将药物从临床前研究转化为实际治疗方面,高达92%的失败率是不可辩护的。值得注意的是,我们的分析通过“路径依赖”的视角来记录事件,这是一种社会科学现象,发生在错误的过去决定锁定未来行动时。最后,我们认识到,我们的叙述偏离了医疗机构的叙述或强大利益集团的谈话要点,包括一些学术精英,他们继续支持以动物为中心的药物开发范式,原因我们也概述了。
{"title":"Path dependency and the rescuing of the biomedical research enterprise.","authors":"Zaher Nahle","doi":"10.3389/fmedt.2025.1683835","DOIUrl":"10.3389/fmedt.2025.1683835","url":null,"abstract":"<p><p>In 2025, three U.S. agencies within the Department of Health and Human Services (FDA, NIH, CDC) alongside EPA and the Departments of the Navy and Veterans Affairs, began substituting animal testing applications with reliable, human-relevant methods. The impact of this shift in public policy taking place at agencies historically bullish on animal testing is still reverberating in the United States and around the world. Here, we examine the circumstances that enabled such momentous reforms, including the role of the FDA Modernization Act 2.0 in advancing new alternative methods, collectively referred to as NAMs. We explain how animal testing, despite its poor value in predicting the safety and efficacy of drugs in humans, came to dominate drug discovery, basic sciences, and environmental toxicity assessments since the inception of the Federal Food, Drug, and Cosmetic Act (Federal FD&C Act) in 1938. Specifically, we identify critical junctures, including catastrophic government decisions, that made the overall research enterprise acutely dependent on animals, leading to the existing predicament-an indefensible 92% failure rate in translating drugs from preclinical studies to actual therapies. Notably, our analysis chronicles events through the lens of \"path dependency,\" a social sciences phenomenon that occurs when faulty past decisions lock-in future action. Finally, we recognize that our narrative is a departure from the medical establishment account or the talking points of powerful interest groups, including some in the academic elite who continue to shore up animal-centric paradigms in drug development for reasons we also outline.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1683835"},"PeriodicalIF":3.8,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12832638/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146069451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
X-ray contrast-adjustable 3D printing for multimodal fusion of microCT and histology. 用于显微ct和组织学多模态融合的x射线可调对比度3D打印。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-09 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1702201
Philipp Nolte, Chris Johann Ackurat, Marcel Brettmacher, Marius Reichardt, Marieke Stammes, Christoph Rußmann, Christian Dullin

Introduction: Phantoms and reference structures are essential tools for calibration and correlative imaging in pre-clinical and research applications of X-ray-based imaging. They serve as reference standards, ensuring consistency and accuracy in imaging results. However, generating individual phantoms often involves a complex creation process, high production costs, and significant time investment.

Material and methods: Conic reference structures were 3D printed using a mixture of UV-curable resin and X-ray contrast agents. These structures were then embedded together with lung specimens of SARS-CoV-2-infected rhesus macaques in a methyl methacrylate-based solution. The polymerized blocks were scanned using propagation-based phase-contrast microCT, a method chosen for its superior ability to enhance contrast, especially in low-absorbing biological samples. Utilizing the conic reference structures, subsequently performed histological sections were co-registered into the 3D context of the microCT datasets.

Results: The produced 3D printed models were highly visible in terms of contrast and detail in both imaging methods, allowing for a precise co-registration of microCT and histological imaging.

Conclusions: The novel methodology of using contrast agents and resin in 3D printing enables the generation of customizable, contrast-specific phantoms and reference structures. These can be straightforwardly segmented from the embedding material, significantly simplifying and enhancing the workflow of multimodal imaging processes. In this study, 3D printed conic reference structures were effectively used to automate and streamline the precise multimodal fusion of microCT and histological imaging.

在x射线成像的临床前和研究应用中,幻影和参考结构是校准和相关成像的重要工具。它们可作为参考标准,确保成像结果的一致性和准确性。然而,生成单个幻影通常涉及复杂的创建过程,高生产成本和大量的时间投资。材料和方法:使用uv固化树脂和x射线造影剂的混合物3D打印锥形参考结构。然后将这些结构与感染sars - cov -2的恒河猴的肺标本一起嵌入基于甲基丙烯酸甲酯的溶液中。聚合块使用基于传播的相衬显微ct扫描,这种方法因其增强对比度的卓越能力而被选择,特别是在低吸收的生物样品中。利用圆锥参考结构,随后进行的组织学切片被共同注册到microCT数据集的3D上下文中。结果:在两种成像方法中,生成的3D打印模型在对比度和细节方面都是高度可见的,允许精确的微ct和组织学成像的共同配准。结论:在3D打印中使用造影剂和树脂的新方法可以生成可定制的,对比度特定的幻影和参考结构。这些可以直接从嵌入材料中分割出来,大大简化和增强了多模态成像过程的工作流程。在本研究中,3D打印的圆锥参考结构被有效地用于自动化和简化微ct和组织学成像的精确多模态融合。
{"title":"X-ray contrast-adjustable 3D printing for multimodal fusion of microCT and histology.","authors":"Philipp Nolte, Chris Johann Ackurat, Marcel Brettmacher, Marius Reichardt, Marieke Stammes, Christoph Rußmann, Christian Dullin","doi":"10.3389/fmedt.2025.1702201","DOIUrl":"10.3389/fmedt.2025.1702201","url":null,"abstract":"<p><strong>Introduction: </strong>Phantoms and reference structures are essential tools for calibration and correlative imaging in pre-clinical and research applications of X-ray-based imaging. They serve as reference standards, ensuring consistency and accuracy in imaging results. However, generating individual phantoms often involves a complex creation process, high production costs, and significant time investment.</p><p><strong>Material and methods: </strong>Conic reference structures were 3D printed using a mixture of UV-curable resin and X-ray contrast agents. These structures were then embedded together with lung specimens of SARS-CoV-2-infected rhesus macaques in a methyl methacrylate-based solution. The polymerized blocks were scanned using propagation-based phase-contrast microCT, a method chosen for its superior ability to enhance contrast, especially in low-absorbing biological samples. Utilizing the conic reference structures, subsequently performed histological sections were co-registered into the 3D context of the microCT datasets.</p><p><strong>Results: </strong>The produced 3D printed models were highly visible in terms of contrast and detail in both imaging methods, allowing for a precise co-registration of microCT and histological imaging.</p><p><strong>Conclusions: </strong>The novel methodology of using contrast agents and resin in 3D printing enables the generation of customizable, contrast-specific phantoms and reference structures. These can be straightforwardly segmented from the embedding material, significantly simplifying and enhancing the workflow of multimodal imaging processes. In this study, 3D printed conic reference structures were effectively used to automate and streamline the precise multimodal fusion of microCT and histological imaging.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1702201"},"PeriodicalIF":3.8,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12827677/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146055742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Nissen vs. Toupet fundoplication in laparoscopic hiatal hernia repair for gastroesophageal reflux disease with extra-esophageal symptoms. Nissen与Toupet翻底术在有食管外症状的胃食管反流病腹腔镜裂孔疝修补术中的比较
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-09 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1678192
Qingchao Zhu, Nengquan Sheng, Zhigang Wang, Yang Xia

Objective: This study aims to evaluate the clinical efficacy of laparoscopic hiatal hernia repair (LHHR) in treating gastroesophageal reflux disease (GERD) and to through the therapeutic effect of total (360°) and partial (270°) laparoscopic fundoplication.

Methods: This retrospective observational study enrolled 100 patients, both with and without documented extra-oesophageal symptoms of GERD. Data were extracted from medical records, covering basic information, symptoms, treatments, and follow-up. Symptom relief and quality of life were assessed via GERD-Q score, Reflux Symptom Index (RSI), and EORTC QLQ-C30 scale, offering a foundation for comprehensive GERD patient management and treatment evaluation in clinical practice.

Results: The DeMeester index significantly decreased postoperatively in both the laparoscopic Nissen fundoplication (LNF) group (from 55.23 ± 25.12 to 11.45 ± 10.20, p < 0.05) and the laparoscopic Toupet fundoplication (LTF) group (from 60.51 ± 28.40 to 11.70 ± 9.65, p < 0.05). The RSI scores improved at 12 months postoperatively in both groups: LNF group (from 23.1 ± 15.4 to 13.7 ± 9.6, p < 0.05) and LTF group (from 21.9 ± 15.8 to 12.8 ± 8.2, p < 0.05). The GERD scores also improved postoperatively: LNF group (from 13 ± 5.0 to 10 ± 4.4, p < 0.05) and LTF group (from 10 ± 4.7 to 7.5 ± 4.5, p < 0.05).

Conclusion: Our report demonstrates that LHHR significantly improved GERD regarding symptom frequency, acid reflux occurrences and DeMeester score. Both LNF and LTF provide good results.

目的:本研究旨在评价腹腔镜裂孔疝修补术(LHHR)治疗胃食管反流病(GERD)的临床疗效,并通过全(360°)和部分(270°)腹腔镜翻底术的治疗效果进行比较。方法:这项回顾性观察性研究纳入了100例患者,包括有或没有食管外症状的胃食管反流。数据从医疗记录中提取,包括基本信息、症状、治疗和随访。采用GERD- q评分、反流症状指数(RSI)和EORTC QLQ-C30量表评估患者的症状缓解和生活质量,为临床对GERD患者进行综合管理和治疗评价提供依据。结果:两组患者术后DeMeester指数均显著降低(从55.23±25.12降至11.45±10.20,p p p p p p p p)。结论:我们的报告显示,LHHR在症状频率、胃酸反流发生率和DeMeester评分方面均显著改善了GERD。LNF和LTF都提供了良好的结果。
{"title":"Comparison of Nissen vs. Toupet fundoplication in laparoscopic hiatal hernia repair for gastroesophageal reflux disease with extra-esophageal symptoms.","authors":"Qingchao Zhu, Nengquan Sheng, Zhigang Wang, Yang Xia","doi":"10.3389/fmedt.2025.1678192","DOIUrl":"10.3389/fmedt.2025.1678192","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to evaluate the clinical efficacy of laparoscopic hiatal hernia repair (LHHR) in treating gastroesophageal reflux disease (GERD) and to through the therapeutic effect of total (360°) and partial (270°) laparoscopic fundoplication.</p><p><strong>Methods: </strong>This retrospective observational study enrolled 100 patients, both with and without documented extra-oesophageal symptoms of GERD. Data were extracted from medical records, covering basic information, symptoms, treatments, and follow-up. Symptom relief and quality of life were assessed via GERD-Q score, Reflux Symptom Index (RSI), and EORTC QLQ-C30 scale, offering a foundation for comprehensive GERD patient management and treatment evaluation in clinical practice.</p><p><strong>Results: </strong>The DeMeester index significantly decreased postoperatively in both the laparoscopic Nissen fundoplication (LNF) group (from 55.23 ± 25.12 to 11.45 ± 10.20, <i>p</i> < 0.05) and the laparoscopic Toupet fundoplication (LTF) group (from 60.51 ± 28.40 to 11.70 ± 9.65, <i>p</i> < 0.05). The RSI scores improved at 12 months postoperatively in both groups: LNF group (from 23.1 ± 15.4 to 13.7 ± 9.6, <i>p</i> < 0.05) and LTF group (from 21.9 ± 15.8 to 12.8 ± 8.2, <i>p</i> < 0.05). The GERD scores also improved postoperatively: LNF group (from 13 ± 5.0 to 10 ± 4.4, <i>p</i> < 0.05) and LTF group (from 10 ± 4.7 to 7.5 ± 4.5, <i>p</i> < 0.05).</p><p><strong>Conclusion: </strong>Our report demonstrates that LHHR significantly improved GERD regarding symptom frequency, acid reflux occurrences and DeMeester score. Both LNF and LTF provide good results.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1678192"},"PeriodicalIF":3.8,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12827679/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146047572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The treatment of challenging visceral and peripheral arterial aneurysms with flow diversion-a German multicentric observational study. 血流分流治疗挑战性内脏和外周动脉动脉瘤-一项德国多中心观察研究。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-06 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1693030
Stefan Schob, Jörg Ukkat, Gregor Scharf, Yvonne Maybaum, Lea Tauber, Clara Lüdeke, Endres John, Karl Julius Büchner, Robert Fiedler, Christian Frahm, Mathias Wieprecht, Silvio Brandt, Mohamed Alsabbagh, Ararat Minasyan, Andreas Simgen, Richard Brill, Jakob Albrecht, Walter Alexander Wohlgemuth, Maximilian de Bucourt, Marie-Sophie Schüngel
<p><strong>Purpose: </strong>Endovascular treatment of visceral and peripheral aneurysms has become the modality of choice over the past few decades. A variety of different techniques are being applied, including deconstructive approaches, such as parent vessel occlusion with coils or liquid embolic agents, and reconstructive approaches, such as stent grafting, stent-assisted coiling, or balloon-assisted coiling. Reconstruction is preferred over vessel or segmental sacrifice due to the risk of ischemia in the dependent territory. However, conventional reconstructive techniques fail, possibly due to the tortuosity of the parent artery or involvement of arterial bifurcations. Flow diversion, a comparatively novel method using densely braided stents, has become well established as a therapeutic option for the treatment of uncoilable or failed aneurysms in cerebral circulation because flow diverter stents can be implanted in highly tortuous vessels and can also be used to treat bifurcation aneurysms without causing occlusion of non-collateralized side branches under sufficient inhibition of platelet function. A few reports have been published on the use of flow diverter stents for the treatment of aneurysms in visceral or peripheral circulation, but systematic studies are lacking. The purpose of this multicenter study is to summarize the experience of different vascular centers that have utilized flow diversion techniques in peripheral vasculature.</p><p><strong>Materials and methods: </strong>This multicentric retrospective analysis includes data from 10 vascular centers on treatments performed between 2022 and 2025. Aside from the safety and feasibility of the approach, procedural aspects, antiplatelet medication, follow-up results, and complications were investigated in a retrospective manner.</p><p><strong>Results: </strong>A total of 36 patients (22 female, with a mean age of 59.2 years, ranging between 36 and 80 years), one with two aneurysms, were treated in the following arterial territories with decreasing frequency: splenic artery (<i>n</i> = 18), hepatic arteries (<i>n</i> = 8), renal artery (<i>n</i> = 7), superior mesenteric artery (<i>n</i> = 1), gastroduodenal artery (<i>n</i> = 1), external iliac artery (<i>n</i> = 1), and inferior genicular artery (<i>n</i> = 1). From a technical perspective, all treatments were performed successfully. A total of four aneurysms (11%) were occluded immediately at the end of the procedure, while in 33 aneurysms (89%), the perfusion was reduced to a varying extent. At the first follow-up study scheduled after 3 months, 17 aneurysms (46%) were occluded, 14 (38%) showed reduced perfusion, and the remaining six patients had not yet undergone follow-up. At 12 months following the procedure, 26 patients with lesions underwent follow-up. A total of 27 aneurysms (73%) were occluded after 12 months, with 17 of them already examined at the 3-month study, two of those without a follow-up at 3 months and one exhib
目的:在过去的几十年里,血管内治疗已成为内脏和周围动脉瘤的首选方式。各种不同的技术正在被应用,包括解构方法,如用线圈或液体栓塞剂闭塞母血管,和重建方法,如支架移植,支架辅助盘绕,或球囊辅助盘绕。重建比血管或节段性牺牲更可取,因为存在依赖区域缺血的风险。然而,传统的重建技术失败,可能是由于动脉弯曲或动脉分叉的累及。血流转移是一种相对较新的方法,使用密集编织支架,已经成为治疗脑循环中不可卷曲或失败的动脉瘤的治疗选择,因为血流转移支架可以植入高度弯曲的血管,也可以在充分抑制血小板功能的情况下用于治疗分叉动脉瘤,而不会导致非侧支闭塞。一些关于使用分流支架治疗内脏或外周循环动脉瘤的报道已经发表,但缺乏系统的研究。本多中心研究的目的是总结不同血管中心在外周血管中应用分流技术的经验。材料和方法:这项多中心回顾性分析包括10个血管中心在2022年至2025年间进行的治疗数据。除了该方法的安全性和可行性外,还对程序方面、抗血小板药物、随访结果和并发症进行了回顾性调查。结果:36例患者(女性22例,平均年龄59.2岁,年龄36 ~ 80岁),其中1例伴2个动脉瘤,分别在脾动脉(18例)、肝动脉(8例)、肾动脉(7例)、肠系膜上动脉(1例)、胃十二指肠动脉(1例)、髂外动脉(1例)、膝下动脉(1例)等动脉区域进行治疗。从技术角度来看,所有的处理都很成功。4个动脉瘤(11%)在手术结束时立即闭塞,33个动脉瘤(89%)灌注不同程度地减少。在3个月后的第一次随访研究中,17个动脉瘤(46%)被闭塞,14个(38%)出现灌注减少,其余6例患者尚未接受随访。手术后12个月,26例病变患者接受随访。12个月后,共有27个动脉瘤(73%)被闭塞,其中17个在3个月的研究中已经检查过,其中2个在3个月时没有随访,1个显示出小的颈部残余。此时,11名动脉瘤患者尚未参加第二次随访研究。2例(5%)出现并发症;一个与氯吡格雷耐药性有关,在干预期间表现为支架闭塞;另一个与治疗动脉瘤无关的出血导致抗血小板治疗暂停有关,在干预后早期表现为支架闭塞。两个病人都恢复得很好。抗血小板药物在各中心之间存在显著差异。结论:我们的多中心观察性研究表明,血流转移作为一种治疗内脏和周围动脉瘤的替代方式具有良好的安全性和有效性。并发症发生率低,所有并发症均与干预期间或干预后早期血小板功能抑制不足有关,可在干预前进行血小板功能检测,然后进行量身定制的抗血小板治疗。
{"title":"The treatment of challenging visceral and peripheral arterial aneurysms with flow diversion-a German multicentric observational study.","authors":"Stefan Schob, Jörg Ukkat, Gregor Scharf, Yvonne Maybaum, Lea Tauber, Clara Lüdeke, Endres John, Karl Julius Büchner, Robert Fiedler, Christian Frahm, Mathias Wieprecht, Silvio Brandt, Mohamed Alsabbagh, Ararat Minasyan, Andreas Simgen, Richard Brill, Jakob Albrecht, Walter Alexander Wohlgemuth, Maximilian de Bucourt, Marie-Sophie Schüngel","doi":"10.3389/fmedt.2025.1693030","DOIUrl":"10.3389/fmedt.2025.1693030","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Purpose: &lt;/strong&gt;Endovascular treatment of visceral and peripheral aneurysms has become the modality of choice over the past few decades. A variety of different techniques are being applied, including deconstructive approaches, such as parent vessel occlusion with coils or liquid embolic agents, and reconstructive approaches, such as stent grafting, stent-assisted coiling, or balloon-assisted coiling. Reconstruction is preferred over vessel or segmental sacrifice due to the risk of ischemia in the dependent territory. However, conventional reconstructive techniques fail, possibly due to the tortuosity of the parent artery or involvement of arterial bifurcations. Flow diversion, a comparatively novel method using densely braided stents, has become well established as a therapeutic option for the treatment of uncoilable or failed aneurysms in cerebral circulation because flow diverter stents can be implanted in highly tortuous vessels and can also be used to treat bifurcation aneurysms without causing occlusion of non-collateralized side branches under sufficient inhibition of platelet function. A few reports have been published on the use of flow diverter stents for the treatment of aneurysms in visceral or peripheral circulation, but systematic studies are lacking. The purpose of this multicenter study is to summarize the experience of different vascular centers that have utilized flow diversion techniques in peripheral vasculature.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;This multicentric retrospective analysis includes data from 10 vascular centers on treatments performed between 2022 and 2025. Aside from the safety and feasibility of the approach, procedural aspects, antiplatelet medication, follow-up results, and complications were investigated in a retrospective manner.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 36 patients (22 female, with a mean age of 59.2 years, ranging between 36 and 80 years), one with two aneurysms, were treated in the following arterial territories with decreasing frequency: splenic artery (&lt;i&gt;n&lt;/i&gt; = 18), hepatic arteries (&lt;i&gt;n&lt;/i&gt; = 8), renal artery (&lt;i&gt;n&lt;/i&gt; = 7), superior mesenteric artery (&lt;i&gt;n&lt;/i&gt; = 1), gastroduodenal artery (&lt;i&gt;n&lt;/i&gt; = 1), external iliac artery (&lt;i&gt;n&lt;/i&gt; = 1), and inferior genicular artery (&lt;i&gt;n&lt;/i&gt; = 1). From a technical perspective, all treatments were performed successfully. A total of four aneurysms (11%) were occluded immediately at the end of the procedure, while in 33 aneurysms (89%), the perfusion was reduced to a varying extent. At the first follow-up study scheduled after 3 months, 17 aneurysms (46%) were occluded, 14 (38%) showed reduced perfusion, and the remaining six patients had not yet undergone follow-up. At 12 months following the procedure, 26 patients with lesions underwent follow-up. A total of 27 aneurysms (73%) were occluded after 12 months, with 17 of them already examined at the 3-month study, two of those without a follow-up at 3 months and one exhib","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1693030"},"PeriodicalIF":3.8,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12816264/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146021041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracellular vesicle signatures from eye lavage as novel non-invasive biomarkers for hypoxic ischaemic insult-findings from a neonatal mouse model. 眼灌洗的细胞外囊泡特征作为缺氧缺血性损伤的新型非侵入性生物标志物——来自新生小鼠模型的发现。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-12-18 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1715676
Runci Li, Sarah R Needham, Igor Kraev, Mariya Hristova, Sigrun Lange

Neonatal hypoxia ischaemia (HI) affects 1-3 per 1,000 live births, is a major cause of infant mortality and morbidity, and leads to adverse long-term neurological outcomes, while reliable biomarkers are scarce. Extracellular vesicles (EVs) are small membrane vesicles released from cells and play key roles in cellular communication through the transfer of diverse cargoes, including proteins, and can be isolated from various body fluids. Here, we developed a new non-invasive method of biofluid-EV profiling, isolating EVs from eye lavage. Our data demonstrate that in a neonatal HI mouse model of mild and severe insults, significant differences are found in EV eye lavage signatures. We identified increased EV numbers and modifications in EV size profiles and EV's proteomic cargo signatures in eye lavage from HI animals compared to controls. A protein-protein interaction network analysis of the EV proteome cargoes identified enrichment in Gene Ontology and Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathways in the HI groups associated with various homeostatic and disease-related pathways. The specific changes in the mild HI group included pathways for ribosome biogenesis, translation, RNA processing, gene expression, blood coagulation, innate immunity, antioxidant activity, phospholipid binding, post-synapse, cell cortex, and HIF-1 signalling. The enriched pathways only associated with the EV proteome of the severe HI group included cytoskeleton organisation, peptide cross-linking, monosaccharide biosynthesis, peroxidase activity, extrinsic component of plasma membrane, the GAIT complex, mast cell granulation, ruffle, and sealing of the nuclear envelope by the endosomal sorting complex required for transport III. Here, we report a new non-invasive method using eye lavage EV signatures to identify changes in response to HI. Our results highlight eye lavage EVs as potential clinical biomarkers for predicting changes that occur in the brain and eye due to different neonatal HI injury severities.

新生儿缺氧缺血性(HI)影响1-3 / 1000活产婴儿,是婴儿死亡率和发病率的主要原因,并导致不良的长期神经系统预后,而可靠的生物标志物很少。细胞外囊泡(EVs)是从细胞中释放出来的小膜囊泡,在细胞通信中发挥关键作用,通过多种货物(包括蛋白质)的转移,可以从各种体液中分离出来。在此,我们开发了一种新的非侵入性生物流体- ev分析方法,从眼灌洗液中分离ev。我们的数据表明,在轻度和重度损伤的新生儿HI小鼠模型中,EV洗眼信号存在显著差异。我们发现,与对照组相比,在HI动物的眼睛冲洗中,EV数量增加,EV大小谱和EV蛋白质组学特征发生了变化。对EV蛋白质组的蛋白质相互作用网络分析发现,在HI组中,与各种稳态和疾病相关途径相关的基因本体和京都基因与基因组百科全书(KEGG)途径中富集。轻度HI组的特异性变化包括核糖体生物发生、翻译、RNA加工、基因表达、血液凝固、先天免疫、抗氧化活性、磷脂结合、突触后、细胞皮层和HIF-1信号传导途径。仅与严重HI组EV蛋白质组相关的富集途径包括细胞骨架组织、肽交联、单糖生物合成、过氧化物酶活性、质膜的外部成分、步态复合物、肥大细胞肉芽化、褶皱以及运输所需的内体分选复合物对核膜的密封III。在这里,我们报告了一种新的非侵入性方法,使用眼灌洗EV特征来识别HI反应的变化。我们的研究结果强调了眼灌洗EVs作为潜在的临床生物标志物,可以预测不同新生儿HI损伤严重程度导致的大脑和眼睛变化。
{"title":"Extracellular vesicle signatures from eye lavage as novel non-invasive biomarkers for hypoxic ischaemic insult-findings from a neonatal mouse model.","authors":"Runci Li, Sarah R Needham, Igor Kraev, Mariya Hristova, Sigrun Lange","doi":"10.3389/fmedt.2025.1715676","DOIUrl":"10.3389/fmedt.2025.1715676","url":null,"abstract":"<p><p>Neonatal hypoxia ischaemia (HI) affects 1-3 per 1,000 live births, is a major cause of infant mortality and morbidity, and leads to adverse long-term neurological outcomes, while reliable biomarkers are scarce. Extracellular vesicles (EVs) are small membrane vesicles released from cells and play key roles in cellular communication through the transfer of diverse cargoes, including proteins, and can be isolated from various body fluids. Here, we developed a new non-invasive method of biofluid-EV profiling, isolating EVs from eye lavage. Our data demonstrate that in a neonatal HI mouse model of mild and severe insults, significant differences are found in EV eye lavage signatures. We identified increased EV numbers and modifications in EV size profiles and EV's proteomic cargo signatures in eye lavage from HI animals compared to controls. A protein-protein interaction network analysis of the EV proteome cargoes identified enrichment in Gene Ontology and Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathways in the HI groups associated with various homeostatic and disease-related pathways. The specific changes in the mild HI group included pathways for ribosome biogenesis, translation, RNA processing, gene expression, blood coagulation, innate immunity, antioxidant activity, phospholipid binding, post-synapse, cell cortex, and HIF-1 signalling. The enriched pathways only associated with the EV proteome of the severe HI group included cytoskeleton organisation, peptide cross-linking, monosaccharide biosynthesis, peroxidase activity, extrinsic component of plasma membrane, the GAIT complex, mast cell granulation, ruffle, and sealing of the nuclear envelope by the endosomal sorting complex required for transport III. Here, we report a new non-invasive method using eye lavage EV signatures to identify changes in response to HI. Our results highlight eye lavage EVs as potential clinical biomarkers for predicting changes that occur in the brain and eye due to different neonatal HI injury severities.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1715676"},"PeriodicalIF":3.8,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12756510/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145901978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FE-based risk assessment of coronary artery compression in pulmonary conduit pre-stenting: optimizing the balance between time-expense and reliability. 基于fe的肺动脉支架预植入术冠状动脉压迫风险评估:优化时间费用与可靠性之间的平衡。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-12-18 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1686131
Davide Astori, Francesco Sturla, Alessandro Caimi, Francesco Secchi, Luca Giugno, Alberto Redaelli, Mario Carminati, Emiliano Votta

Background and objective: Calcific obstruction of the pulmonary conduit is a late complication of surgical implantation of a homograft in congenital patients. Percutaneous pulmonary valve implantation (PPVI) is an effective alternative to surgical repair. However, this procedure is affected by several complications, with coronary artery (CA) compression being one of the most severe. High-fidelity finite element (FE) models can provide accurate predictions but are too computationally expensive for routine use, whereas simplified models sacrifice mechanical fidelity. This study proposes a novel FE-based framework to investigate conduit pre-stenting feasibility, while aiming to balance computational efficiency with predictive accuracy within clinically relevant timelines.

Methods: A semi-automated pipeline was developed, requiring manual input only for the segmentation of computed tomography (CT), virtual stent positioning, and simulation launch. Patient-specific geometries were meshed and processed through an automated in-house script, generating ready-to-run Abaqus input files. A multifactorial CA compression risk index was introduced, integrating baseline and post-expansion distances between the pulmonary artery and CA, and their changes during the procedure. The FE simulation of the pre-stenting procedure was tested on 10 PPVI candidates, simulating CP-stent implantation. Simulation accuracy was assessed against fluoroscopy-derived stent diameters.

Results: The full simulation process required less than 10 h per case, with minimal operator workload. FE-predicted stent configuration showed strong agreement with fluoroscopic measurements ( R 2 = 0.87), with a mean absolute error of 3.5 ± 4.4%. Accuracy was highest in patients with calcific volumes <0.8  cm 3 (error <0.5 mm). CA compression index identified 2 high-risk, 2 moderate-risk, and 6 negligible-risk patients. Peri-procedural fluoroscopy was not available for one negligible-risk patient; it excluded CA compression for the remaining negligible-risk patients (true negatives), for all moderate-risk patients, and for one high-risk patient (false positive); it highlighted CA compression for the remaining high-risk patient (true positive).

Conclusions: The proposed FE simulation framework enables patient-specific prediction of stent configuration and CA compression risk within clinically compatible timelines. The balanced trade-off between mechanical fidelity and computational efficiency supports its potential integration into pre-procedural planning of conduit pre-stenting and PPVI.

背景与目的:肺导管钙化性梗阻是先天性同种异体移植物植入术的晚期并发症。经皮肺动脉瓣植入术(PPVI)是手术修复的有效选择。然而,该手术受到几种并发症的影响,冠状动脉(CA)压迫是最严重的并发症之一。高保真有限元(FE)模型可以提供准确的预测,但对于日常使用来说计算成本太高,而简化模型则牺牲了机械保真度。本研究提出了一种新的基于fe的框架来研究导管预支架置入的可行性,同时旨在平衡计算效率和临床相关时间内的预测准确性。方法:开发了半自动化流水线,仅需要人工输入计算机断层扫描(CT)分割、虚拟支架定位和模拟发射。特定于患者的几何图形通过自动化的内部脚本进行网格化和处理,生成随时可以运行的Abaqus输入文件。引入多因素CA压缩风险指数,综合基线和扩张后肺动脉与CA之间的距离及其在手术过程中的变化。对10例PPVI候选者进行预支架植入过程的有限元模拟,模拟cp -支架植入。模拟的准确性根据透视得出的支架直径进行评估。结果:整个模拟过程每个病例需要不到10小时,操作人员的工作量最小。fe预测的支架形态与透视测量结果非常吻合(r2 = 0.87),平均绝对误差为3.5±4.4%。结论:提出的FE模拟框架能够在临床相容的时间线内对患者特异性的支架配置和CA压缩风险进行预测。机械保真度和计算效率之间的平衡平衡支持其潜在的整合到管道预支架植入和PPVI的术前规划中。
{"title":"FE-based risk assessment of coronary artery compression in pulmonary conduit pre-stenting: optimizing the balance between time-expense and reliability.","authors":"Davide Astori, Francesco Sturla, Alessandro Caimi, Francesco Secchi, Luca Giugno, Alberto Redaelli, Mario Carminati, Emiliano Votta","doi":"10.3389/fmedt.2025.1686131","DOIUrl":"10.3389/fmedt.2025.1686131","url":null,"abstract":"<p><strong>Background and objective: </strong>Calcific obstruction of the pulmonary conduit is a late complication of surgical implantation of a homograft in congenital patients. Percutaneous pulmonary valve implantation (PPVI) is an effective alternative to surgical repair. However, this procedure is affected by several complications, with coronary artery (CA) compression being one of the most severe. High-fidelity finite element (FE) models can provide accurate predictions but are too computationally expensive for routine use, whereas simplified models sacrifice mechanical fidelity. This study proposes a novel FE-based framework to investigate conduit pre-stenting feasibility, while aiming to balance computational efficiency with predictive accuracy within clinically relevant timelines.</p><p><strong>Methods: </strong>A semi-automated pipeline was developed, requiring manual input only for the segmentation of computed tomography (CT), virtual stent positioning, and simulation launch. Patient-specific geometries were meshed and processed through an automated <i>in-house</i> script, generating ready-to-run Abaqus input files. A multifactorial CA compression risk index was introduced, integrating baseline and post-expansion distances between the pulmonary artery and CA, and their changes during the procedure. The FE simulation of the pre-stenting procedure was tested on 10 PPVI candidates, simulating CP-stent implantation. Simulation accuracy was assessed against fluoroscopy-derived stent diameters.</p><p><strong>Results: </strong>The full simulation process required less than 10 h per case, with minimal operator workload. FE-predicted stent configuration showed strong agreement with fluoroscopic measurements ( <math><msup><mi>R</mi> <mn>2</mn></msup> </math> = 0.87), with a mean absolute error of 3.5 <math><mo>±</mo></math> 4.4%. Accuracy was highest in patients with calcific volumes <0.8  <math> <msup><mrow><mi>cm</mi></mrow> <mn>3</mn></msup> </math> (error <0.5 mm). CA compression index identified 2 high-risk, 2 moderate-risk, and 6 negligible-risk patients. Peri-procedural fluoroscopy was not available for one negligible-risk patient; it excluded CA compression for the remaining negligible-risk patients (true negatives), for all moderate-risk patients, and for one high-risk patient (false positive); it highlighted CA compression for the remaining high-risk patient (true positive).</p><p><strong>Conclusions: </strong>The proposed FE simulation framework enables patient-specific prediction of stent configuration and CA compression risk within clinically compatible timelines. The balanced trade-off between mechanical fidelity and computational efficiency supports its potential integration into pre-procedural planning of conduit pre-stenting and PPVI.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1686131"},"PeriodicalIF":3.8,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12756087/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145902022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Microbial therapeutics: harnessing the human microbiome for disease treatment and prevention. 社论:微生物疗法:利用人类微生物组进行疾病治疗和预防。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-12-12 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1751147
Ali Asger Bhojiya, Abhinav Saurabh, Devendra Jain
{"title":"Editorial: Microbial therapeutics: harnessing the human microbiome for disease treatment and prevention.","authors":"Ali Asger Bhojiya, Abhinav Saurabh, Devendra Jain","doi":"10.3389/fmedt.2025.1751147","DOIUrl":"https://doi.org/10.3389/fmedt.2025.1751147","url":null,"abstract":"","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1751147"},"PeriodicalIF":3.8,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12741119/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145852017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in medical technology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1